1. Home
  2. SUPN vs HOG Comparison

SUPN vs HOG Comparison

Compare SUPN & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.27

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$27.03

Market Cap

2.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
HOG
Founded
2005
1903
Country
United States
United States
Employees
N/A
6400
Industry
Biotechnology: Pharmaceutical Preparations
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
SUPN
HOG
Price
$48.27
$27.03
Analyst Decision
Strong Buy
Hold
Analyst Count
5
7
Target Price
$61.60
$24.00
AVG Volume (30 Days)
919.1K
2.1M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
3.05%
EPS Growth
N/A
N/A
EPS
N/A
0.97
Revenue
$392,755,000.00
$4,473,175,000.00
Revenue This Year
$22.70
N/A
Revenue Next Year
$19.14
$3.79
P/E Ratio
N/A
$28.64
Revenue Growth
N/A
N/A
52 Week Low
$41.78
$17.09
52 Week High
$59.68
$31.25

Technical Indicators

Market Signals
Indicator
SUPN
HOG
Relative Strength Index (RSI) 54.48 56.18
Support Level $47.58 $24.09
Resistance Level $52.33 $28.77
Average True Range (ATR) 2.42 0.93
MACD 0.21 0.17
Stochastic Oscillator 54.38 73.18

Price Performance

Historical Comparison
SUPN
HOG

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

Share on Social Networks: